Health Matters
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
News Release
NEWS RELEASE: June 14, 2005 Health care leaders create Canada’s first national health advisory body The Canadian Academy of Health Sciences will give Government and the public comprehensive expertise and advice on health issues EDMONTON - When the President of the United States wants advice on a public health issue, he calls the United States’ National Academies. When the Prime Minister of Great Britain wants to seek similar counsel, he usually turns to the Royal Society of Britain. But when the Prime Minister of Canada wants similar advice, who does he call? Well, that’s not always entirely clear, given the more narrowly defined mandates of many Canadian organizations. Now, however, owing to a recent initiative by a group of leading health care leaders and researchers, the Prime Minister will be able to call the Canadian Academy of Health Sciences (CAHS), recently created to: • Develop informed, strategic assessments on urgent health issues; • Inform public policy on these issues; • Enhance Canada’s readiness to deal with global health issues; and, • Provide a recognized and authoritative Canadian health science voice internationally. According to one of the Academy’s key organizers, the establishment of the Academy is long over due—and all the more pressing given the potential global health threats to Canadians, most recently exemplified by the SARS threat. “Ask Canadians what they care about most, and they answer unequivocally: ‘health,’” explains University of Alberta Professor of Medicine Paul Armstrong, CAHS’s first president. “It makes sense, therefore, that Canada should have an organization that government—and Canadians—can turn to for sound, impartial advice and research on pressing health issues.” The organization will also have an international role to play, representing Canada’s interests abroad and working closely with other nations’ parallel agencies. -
Printable List of Laureates
Laureates of the Canadian Medical Hall of Fame A E Maude Abbott MD* (1994) Connie J. Eaves PhD (2019) Albert Aguayo MD(2011) John Evans MD* (2000) Oswald Avery MD (2004) F B Ray Farquharson MD* (1998) Elizabeth Bagshaw MD* (2007) Hon. Sylvia Fedoruk MA* (2009) Sir Frederick Banting MD* (1994) William Feindel MD PhD* (2003) Henry Barnett MD* (1995) B. Brett Finlay PhD (2018) Murray Barr MD* (1998) C. Miller Fisher MD* (1998) Charles Beer PhD* (1997) James FitzGerald MD PhD* (2004) Bernard Belleau PhD* (2000) Claude Fortier MD* (1998) Philip B. Berger MD (2018) Terry Fox* (2012) Michel G. Bergeron MD (2017) Armand Frappier MD* (2012) Alan Bernstein PhD (2015) Clarke Fraser MD PhD* (2012) Charles H. Best MD PhD* (1994) Henry Friesen MD (2001) Norman Bethune MD* (1998) John Bienenstock MD (2011) G Wilfred G. Bigelow MD* (1997) William Gallie MD* (2001) Michael Bliss PhD* (2016) Jacques Genest MD* (1994) Roberta Bondar MD PhD (1998) Gustave Gingras MD* (1998) John Bradley MD* (2001) Phil Gold MD PhD (2010) Henri Breault MD* (1997) Richard G. Goldbloom MD (2017) G. Malcolm Brown PhD* (2000) Jean Gray MD (2020) John Symonds Lyon Browne MD PhD* (1994) Wilfred Grenfell MD* (1997) Alan Burton PhD* (2010) Gordon Guyatt MD (2016) C H G. Brock Chisholm MD (2019) Vladimir Hachinski MD (2018) Harvey Max Chochnov, MD PhD (2020) Antoine Hakim MD PhD (2013) Bruce Chown MD* (1995) Justice Emmett Hall* (2017) Michel Chrétien MD (2017) Judith G. Hall MD (2015) William A. Cochrane MD* (2010) Michael R. Hayden MD PhD (2017) May Cohen MD (2016) Donald O. -
Prospectus for a Major Assessment: the Return on Investments in Health Research
Prospectus for a Major Assessment: The Return on Investments in Health Research: Defining the Best Metrics Prepared by the Canadian Academy of Health Sciences May 2007 WO The Return on Investments in Canadian Health Research – The Situation Investments in health research have increased significantly across Canada over the past decade. Naturally, and justifiably, with these greater investments come increased expectations. In addition, the widening diversity of stakeholders engaged in and/or supporting health research has led to a broader range of anticipated outcomes. These expectations include: 1] better health; 2] greater life expectancy; 3] translation of research findings into improvements in quality of life; 4] informed public policy on health related issues across the full spectrum of government and private sector activity; 5] new commercial opportunities within and beyond Canadian borders; 6] increased attraction of the next generation to pursue careers in health research and the health sector; 7] a better ‘state of readiness” for the unexpected threats to health that inevitably develop in the contemporary world. In parallel with these expectations, a confluence of factors has placed intense focus on understanding what return our society receives for the investments made in health research. Some of these include: • lack of public understanding of the value of research and its applicability to current issues in health care at a time of unsurpassed concern about accessible, affordable, high quality health care in a publicly funded -
8 Montarville (De) 1 469 717 2 764 1 472 481 Montréal-Nord Et Tremblay Inc
gouvernement du Québec comptes publics année financière terminée le 31 mars 1987 dl O □ volume 2 détail des dépenses • fournisseurs et bénéficiaires • biens en capital Publiés conformément aux dispositions de l’article 71 de la Loi sur l’adm inistration (L.R.Q., c.A-6) Mfrîfcîcra dss Finanças Gouvernement du Québec Ministère des Finances Date: -•> \ " ; ü ; ISSN 0706-2869 ISBN 2-550-17824-6 (Édition complète) ISBN 2-550-17826-2 (Volume 2) Dépôt légal — 4e trimestre 1987 Bibliothèque nationale du Québec TABLE DES MATIERES SECTION LISTE DES FOURNISSEURS ET BÉNÉFICIAIRES 1 LISTE DES BIENS EN CAPITAL 2 1-1 SECTION 1 LISTE DES FOURNISSEURS ET BÉNÉFICIAIRES Pour chaque catégorie de dépenses, sauf « Dépenses de trans NOTE fert», la liste des fournisseurs et bénéficiaires est émise au niveau du ministère selon les limites et critères de publication suivants: a) Traitements, salaires, allocations et autres rémunérations: Ne sont pas détaillées au i wm des fournisseurs et bénéficiaires les sommes — Ministres, sous-ministres et hauts fonctionnaires de rang équi ayant été versées à «Oiverses personnes» à savoir: valent: tout montant; Allocations aux propriétaires de forêts privées dans le cadre des intérêts sur — Personnel cadre (administrateurs, directeurs de cabinet et leurs emprunts auprès du crédit forestier (Office du crédit agricole du Qué fonctionnaires de rang équivalent): tout montant; bec) et aux agriculteurs dans le cadre des intérêts sur leurs emprunts auprès — Toute allocation: 11 000 $ et plus; de l'Office du crédit agricole du Québec, du crédit agricole par les institu — Contributions de l’employeur: 22 000 $ et plus. tions privées, de l’amélioration des fermes, du crédit à la production, du cré dit spécial, du prêt agricole (Société du crédit agricole du Canada), de la b) Autres catégories: 22 000 $ et plus, sauf le Service de la dette mise en valeur des exploitations agricoles, du réaménagement foncier et dont le détail n’est pas publié. -
2011/2012 Annual Report
BUILDINGALEGACY Stem Cell Network 2011-2012 Annual Report StemCell Network 2011-2012 Annual Report TABLE OF CONTENTS Directors’ Message .........................................................................................2 Bridging The Translational Gap ...................................................................4 In Profile: Dr. Denis-Claude Roy .............................................7 The High-Throughput Revolution................................................................8 In Profile: Dr. Aaron Schimmer .........................................11 See The Potential: An Industry-Academia Hybrid ...............................12 In Profile: Dr. Corinne Hoesli ..............................................14 A Research Conference Built by the Community .................................15 In Profile: Dr. Peter Zandstra .............................................17 Building an Informed Public.......................................................................18 In Profile: Angela McDonald .............................................21 Network Community ...................................................................................22 2011-12 Financial Statements ...................................................................25 Directors’ Message Message from SCN’s Board Chair, Scientific Director, and Executive Director t’s year 12. On paper, the Stem Cell Network has entered its for blood cancers at the University of Montréal. Dr. Roy’s project, sunset years, but we’re not ready to rest on our laurels -
Lauréats Du Temple De La Renommée Médicale Canadienne
Lauréats du Temple de la renommée médicale canadienne A Maude Abbott MD* (1994) E Albert Aguayo MD (2011) Connie J. Eaves PhD (2019) Oswald Avery MD* (2004) John Evans MD* (2000) B F Elizabeth Bagshaw MD* (2007) Ray Farquharson MD* (1998) Sir Frederick Banting MD* (1994) L’honorable Sylvia Fedoruk* (2009) Henry Barnett MD* (1995) William Feindel MD PhD* (2003) Murray Barr MD* (1998) B. Brett Finlay PhD (2018) Charles Beer PhD* (1997) C. Miller Fisher MD* (1998) Bernard Belleau PhD* (2000) James FitzGerald MD PhD* (2004) Philip B. Berger MD (2018) Claude Fortier MD* (1998) Michel G. Bergeron MD (2017) Terry Fox* (2012) Alan Bernstein PhD (2015) Armand Frappier MD* (2012) Charles H. Best MD PhD* (1994) F. Clarke Fraser MD PhD* (2012) Norman Bethune MD* (1998) Henry Friesen MD (2001) John Bienenstock MD (2011) Wilfred G. Bigelow MD* (1997) G Michael Bliss PhD* (2016) William Gallie MD* (2001) Roberta Bondar MD PhD (1998) Jacques Genest MD* (1994) John Bradley MD* (2001) Gustave Gingras MD* (1998) Henri Breault MD* (1997) Phil Gold MD PhD (2010) G. Malcolm Brown PhD* (2000) Richard G. Goldbloom MD (2017) John Symonds Lyon Browne MD PhD* (1994) Jean Gray MD (2020) Alan Burton PhD* (2010) Wilfred Grenfell MD* (1997) Gordon Guyatt MD (2016) C G. Brock Chisholm MD (2019) H Harvey Max Chochinov MD PhD (2020) Vladimir Hachinski MD (2018) Bruce Chown MD* (1995) Antoine Hakim MD PhD (2013) Michel Chrétien MD (2017) Juge Emmett Hall* (2017) William A. Cochrane MD* (2010) Judith G. Hall MD (2015) May Cohen MD (2016) Michael R. Hayden MD PhD (2017) James Collip MD PhD* (1994) Donald O. -
Charles Scriver Interview
CHARLES SCRIVER INTERVIEW First Session - August 22, 2006 1. Family Background and Education NC: It is August 22nd, 2006, and this is Nathaniel Comfort. I'm in Montreal, Quebec, Canada, at the Montreal Children's Hospital, and we're doing the oral history interview with Charles Scriver. Would you first just state your full name? CS: Charles Robert Scriver. NC: It's great to be here, Dr. Scriver. I'm really looking forward to talking with you. What I'd like to do is just begin at the very beginning and have you tell me a little bit about your childhood and background and your parents and what it was like growing up. CS: It's a very unglamorous history compared to how people move around the world today. I was born in Montreal, I was educated in Montreal, I've worked in Montreal, I'm going to die in Montreal. NC: When were you born? CS: I was born November 7th, 1930. I had parents who were both physicians and both on the faculty at McGill University. I was an only child. My mother was thirty-seven when I was born. It was a rather particular influence that, with my mother, who was a working mother in the 1930s, even though she was professional and from a place that didn't have to work, it was her moral obligation to use the opportunities she had been given to study medicine at McGill University. She was in the first class to tolerate women. She became a role model for women students after that. -
History of the First 30 Years of the Canadian Association of Gastroenterology L'association Canadienne De Gastroentérologie
HISTORY OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY History of the first 30 years of the Canadian Association of Gastroenterology L’Association canadienne de gastroentérologie, les 30 premières années IVAN TBECK, MD, PHD, FRCPC, FACP, MACG N 1992 THE CANADIAN ASSOCIATION review the documents and remembered the Association, who indicated that Iof Gastroenterology (CAG) reached and relived some of the major events the Board of the CAG would like me to its 30th anniversary. Much has hap- which constitute the history of the write an extended book-size history of pened and many changes occurred dur- CAG, my enthusiasm rose, and I be- our first 30 years. I have now started ing the first 30 years of this came more and more involved and writing this manuscript. However this Association; this anniversary presented stimulated to write the chapter on the monograph may not be ready and avail- an opportune time to document some CAG for Dr Morley’s book. Once com- able to our membership for some time. of the major events that occurred dur- pleted, this was submitted and the book Therefore I decided to write this abbre- ing these years. was published in 1991 (1). viated form of our history, which can My stimulus to become involved in I feel that much has happened in be made available rapidly, hopefully for this undertaking was in 1989 when the 1990 and 1991 to warrant an extension your enjoyment. Some of this material Royal College of Physicians and Sur- to include the first 30 years of the CAG was included in the chapter of Dr Mor- geons of Canada (RCPSC) requested and thus finish the history at an impor- ley’s book and he gave me permission Dr Iain Cleator, our President, to con- tant anniversary. -
Canadian Asset Map for Stem Cell
CANADIAN ASSET MAP FOR STEM CELL AND REGENERATIVE MEDICINE This publication is also available online in HTML and .pdf formats at www.ic.gc.ca/stemcells This publication is available upon request in accessible formats. Contact: Multimedia Services Section Communications and Marketing Branch Industry Canada Room 441E, East Tower 235 Queen Street Ottawa ON K1A 0H5 Telephone: 613-995-8552 Fax: 613-954-6436 Email: [email protected] Aussi offert en français sous le titre : Carte des ressources canadiennes dans les domaines des cellules souches et de la médecine régénérative Cette publication est disponible en ligne en formats HTML et pdf à www.ic.gc.ca/cellulessouches Release Note: Published by Industry Canada, March 2012. To obtain an electronic copy of this report, please visit www.ic.gc.ca/stemcells PERMISSION TO REPRODUCE: Non-commercial Reproduction Except as otherwise specifically noted, the information in this publication may be reproduced, in part or in whole and by any means, without change or further permission for non-commercial re-distribution, provided that due diligence is exercised in ensuring the accuracy of the information reproduced; that International BioPharma Solutions Ltd. is identified as the source; and that the reproduction is not represented as an official version of the information reproduced, nor as having been made in affiliation with, or with the endorsement of Industry Canada or International BioPharma Solutions Ltd. Commercial Reproduction Reproduction of materials in this document, in whole or in part, for the purposes of commercial redistribution is prohibited except with written permission from International BioPharma Solutions Ltd. For permission to reproduce the information in this publication for commercial redistribution, please contact : International BioPharma Solutions Ltd.